Boehringer Ingelheim Buys Cellomics Automated Cell Imaging Technology | GenomeWeb

NEW YORK, Aug. 3 – Cellomics has sold its ArrayScan HCS system for imaging cells to Boehringer Ingelheim Pharmaceuticals, Cellomics said on Friday.

The giant German pharma company will use the system to automate its drug-discovery process, the company said in a statement.

Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.